EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice

Susan MacLauchlan iD, Priyanka Kushwaha, Albert Tai iD, Sijia Chen, Catherine Manning iD, Gaurav Swarnkar iD, Yousef Abu-Amer iD, Katherine A Fitzgerald, Shruti Sharma iD, Ellen M Gravallese iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2210409120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Susan MacLauchlan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115. Hauptthemen laut MEDLINE: Osteoclasts, Signal Transduction. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimulator of interferon genes (STING) is a key mediator of type-I interferon (IFN-I) signaling in response to a variety of stimuli, but the contribution of STING to homeostatic processes is not fully characterized. Previous studies showed that ligand activation of STING limits osteoclast differentiation in vitro through the induction of IFNβ and IFN-I interferon-stimulated genes (ISGs). In a disease model (SAVI) driven by the V154M gain-of-function mutation in STING, fewer osteoclasts form from SAVI precursors in response to receptor activator of NF-kappaB ligand (RANKL) in an IFN-I-dependent manner. Due to the described role of STING-mediated regulation of osteoclastogenesis in activation settings, we sought to determine whether basal STING signaling contributes to bone homeostasis, an unexplored area. Using whole-body and myeloid-specific deficiency, we show that STING signaling prevents trabecular bone loss in mice over time and that myeloid-restricted STING activity is sufficient for this effect. STING-deficient osteoclast precursors differentiate with greater efficiency than wild types. RNA sequencing of wild-type and STING-deficient osteoclast precursor cells and differentiating osteoclasts reveals unique clusters of ISGs including a previously undescribed ISG set expressed in RANKL naïve precursors (tonic expression) and down-regulated during differentiation. We identify a 50 gene tonic ISG signature that is STING dependent and shapes osteoclast differentiation. From this list, we identify interferon-stimulated gene 15 (ISG15) as a tonic STING-regulated ISG that limits osteoclast formation. Thus, STING is an important upstream regulator of tonic IFN-I signatures shaping the commitment to osteoclast fates, providing evidence for a nuanced and unique role for this pathway in bone homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsSignal TransductionAnimalsMiceCell DifferentiationInterferonsLigandsMice, Inbred C57BLRANK LigandSTING Protein

Stichwörter der Autor:innen

STINGbone homeostasisinterferonosteoimmunology

Substanzen

InterferonsLigandsRANK LigandSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
  • Department of Immunology, Tufts University School of Medicine, Boston, MA 02111.
  • Department of Orthopedics and Cell Biology and Physiology, Washington University School of Medicine, Saint Louis, MO 63110.
  • Department of Medicine, Program in Innate Immunity, University of Massachusetts Chan Medical School, Worcester, MA 01655.

ORCID-Profile: Susan MacLauchlan, Albert Tai, Catherine Manning, Gaurav Swarnkar, Yousef Abu-Amer, Shruti Sharma, Ellen M Gravallese

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • Arthritis National Research Foundation
  • Lupus Research Alliance

Zitieren

APA

MacLauchlan, S., Kushwaha, P., Tai, A., Chen, S., Manning, C., Swarnkar, G., Abu-Amer, Y., Fitzgerald, K. A., Sharma, S., & Gravallese, E. M. (2023). STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2210409120

Vancouver

MacLauchlan S, Kushwaha P, Tai A, Chen S, Manning C, Swarnkar G, et al. STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2210409120

BibTeX
@article{MacLauchlan2023,
  author = {MacLauchlan, Susan and Kushwaha, Priyanka and Tai, Albert and Chen, Sijia and Manning, Catherine and Swarnkar, Gaurav and Abu-Amer, Yousef and Fitzgerald, Katherine A and Sharma, Shruti and Gravallese, Ellen M},
  title = {STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2210409120}
}
Kostenlos starten →